ULTRACAL XS
Received May 19, 2020 · Event occurred Aug 8, 2017
Report 1718912-2019-00002 · MDR key 10070882
Device
Generic name
Liner Cavity/calicium Hydroxide
Manufacturer
Ultradent Products, IncCatalog number
606
Lot number
UNKNOWN
Product problems
- Use of Device Problem
- Use of Device Problem
Patient
56 YR
- Patient Problem/Medical Problem
- Patient Problem/Medical Problem
Narrative
Additional Manufacturer Narrative
IT HAS BEEN WIDELY KNOWN SINCE AT LEAST 1920 THAT CALCIUM HYDROXIDE HAS GREAT HEALING POWERS IN THE TOOTH DUE TO ITS HIGH PH, WHICH KILLS MICROORGANISMS IN TEETH AND ITS BIOACTIVITY TO REGENERATE TOOTH AT THE APEX. IN THIS CASE, BASED ON THE INFORMATION RECEIVED THUS FAR IN THE LITIGATION, THE GROSS OVER EXTRUSION OF ULTRACAL (CALCIUM HYDROXIDE) PAST THE APICAL FORAMEN IN A LOWER FIRST MOLAR RESULTED IN ALLEGED LONG-TERM PAIN, PARESTHESIA, AND EVENTUAL EXTRACTION OF THE INVOLVED TOOTH. HAVING THIS ALLEGED SEQUELAE HAPPEN AS A RESULT OF ROOT CANAL TREATMENT CAN HAPPEN, BUT IT IS DEFINITELY NOT THE STANDARD OF CARE IN ENDODONTICS TO HAVE THIS HAPPEN. IT HAS BEEN WELL KNOWN FOR ALL THESE YEARS. DENTISTS RECEIVE TRAINING IN DENTAL SCHOOL AND ANNUAL CONTINUING EDUCATION TRAINING THAT AN EXTRUSION (MISUSE) OF THIS CHEMICAL OUTSIDE THE CONFINES OF THE TOOTH MAY CAUSE THE PATIENT TO HAVE ISSUES SIMILAR TO THOSE ALLEGED TO HAVE OCCURRED HERE.
Description of Event or Problem
PATIENT CLAIMS "BURNING AND NUMBNESS IN HIS LOWER LEFT FACE."